SKYE
Skye Bioscience, Inc.
1.70$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.9% | -4.3% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 3.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -15.9% | 35.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0% | 14.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -11.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 65.0% | 23.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 76.9% | 7.6% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 11.9% | -18.7% | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.